https://www.selleckchem.com/products/pfi-3.html
This is the first-in-human immunotherapy study using deceased donor liver-derived NK cells to prevent HCC recurrence after LT. This treatment was well tolerated and resulted in no HCC recurrence after LT.Clinical trial registration www.clinicaltrials.gov ; NCT01147380; registration date June 17, 2010. The aim of the present study was to examine the retention force of monolithic zirconia copings cemented with various temporary cements on implant abutments in vitro. Sixty exercise implants with pre-screwed implant abutments were embedded in
Like
Comment
Share
